MedDataX Logo

Zinc Supplementation of Imipramine Therapy

NCT00693680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-06-13

No results posted yet for this study

Summary

Examination of the effect of zinc supplementation on imipramine therapy in major depression.

Conditions

  • Major Depression

Interventions

DIETARY_SUPPLEMENT

Zincas Forte

25 mgZn/day + imipramine (100-200mg/day)

DIETARY_SUPPLEMENT

Placebo

placebo + imipramine (100-200mg/day)

Sponsors & Collaborators

  • Jagiellonian University

    collaborator OTHER

  • Polish Academy of Sciences

    lead OTHER

Principal Investigators

  • Andrzej Zieba, Prof. · Department of Psychiatry, Collegium Medicum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • Poland

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00693680 on ClinicalTrials.gov